Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coated or Chewable Aspirin in Patients with Established Atherosclerotic Disease and a Hybrid Strategy to Mitigate the Adverse Effects of Air Pollution: the COATED-AIR Randomized Clinical Trial

NCT06541691 is registered in ClinicalTrials.gov with Rajaie Cardiovascular Medical and Research Center as lead sponsor.

NCT NCT06541691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06541691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coated or Chewable Aspirin in Patients with Established Atherosclerotic Disease and a Hybrid Strategy to Mitigate the Adverse Effects of Air Pollution: the COATED-AIR Randomized Clinical Trial
Lead sponsor
Rajaie Cardiovascular Medical and Research Center
Phase
Not applicable
Overall status
Recruiting
Start date
March 6, 2024
Completion date
March 30, 2027
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease, carotid artery stenosis, carotid atherosclerosis, coronary artery disease, ischemic heart disease, ischemic stroke, peripheral arterial disease